PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...
BOSTON - Seaport Therapeutics, a clinical-stage biopharmaceutical company, has published new research demonstrating significant advancements in drug delivery through the lymphatic system using its ...
While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to ...
Lakewood-Amedex Inc., a privately held, clinical-stage pharmaceutical discovery and development company advancing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called ...
AbbVie and Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for ...
The Trump administration’s announced cuts to research funding could cost two of Arkansas’ major healthcare centers millions ...
Arkansas research institutions stand to lose millions in research funding due to cuts planned by the administration of ...
Three years after moving into her Charlotte apartment, she’s lost nearly all of her belongings in what she calls “the worse ...
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback